Therefore, Tgfbr2 deletion in the bone marrow mirrors diabetes-induced changes such that reduced expression of the TGFB pathway, including the downstream mediators, may remove the suppression and allow bm-MPCs to readily differentiate into adipocytes. The gene discussed is TGFBR2; the disease is diabetes mellitus.